United Kingdom (UK)

1 September 2020 - 31 August 2021

Subject/journal group: All

The table to the right includes counts of all research outputs for United Kingdom (UK) published between 1 September 2020 - 31 August 2021 which are tracked by the Nature Index.

Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

Count Share
7835 3626.68

Outputs by subject (FC)

Subject Count Share
Life Sciences 3576 1626.02
56 12.39
9 2.81
36 16.07
69 23.73
10 3.73
15 5.44
26 12.68
101 49.65
26 13.81
43 17.95
12 7.01
29 15.69
13 6.95
92 51.11
45 28.22
44 12.09
31 10.77
88 49.59
44 20.84
59 20.76
151 63.70
19 4.26
17 8.53
9 2.79
879 382.37
54 17.56
19 7.28
60 21.52
Microglial activation and tau propagate jointly across Braak stages
2021-08-26
0.11
Mitochondrial DNA variants modulate -formylmethionine, proteostasis and risk of late-onset human diseases
2021-08-23
0.93
Pirfenidone in heart failure with preserved ejection fraction: a randomized phase 2 trial
2021-08-12
0.94
Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial
2021-08-12
0.05
Fully automated closed-loop glucose control compared with standard insulin therapy in adults with type 2 diabetes requiring dialysis: an open-label, randomized crossover trial
2021-08-04
0.60
COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries
2021-07-16
0.04
mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar
2021-07-09
0.01
Evaluation of the extended efficacy of the Dengvaxia vaccine against symptomatic and subclinical dengue infection
2021-06-24
0.03
A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer’s disease
2021-06-21
0.01
Deep learning of HIV field-based rapid tests
2021-06-17
0.56
Danuglipron (PF-06882961) in type 2 diabetes: a randomized, placebo-controlled, multiple ascending-dose phase 1 trial
2021-06-14
0.13
First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland
2021-06-09
0.98
Impact of vaccination on new SARS-CoV-2 infections in the United Kingdom
2021-06-09
1
Hematopoietic mosaic chromosomal alterations increase the risk for diverse types of infection
2021-06-07
0.06
Childhood amyotrophic lateral sclerosis caused by excess sphingolipid synthesis
2021-05-31
0.07
Loss-of-function mutations in the melanocortin 4 receptor in a UK birth cohort
2021-05-27
1
Cytokine release syndrome in a patient with colorectal cancer after vaccination with BNT162b2
2021-05-26
0.94
Partial recovery of visual function in a blind patient after optogenetic therapy
2021-05-24
0.06
Prediction of future Alzheimer’s disease dementia using plasma phospho-tau combined with other accessible measures
2021-05-24
0.05
Author Correction: T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial
2021-05-21
0.98
An adaptive, biomarker-directed platform study of durvalumab in combination with targeted therapies in advanced urothelial cancer
2021-05-03
0.50
Four distinct trajectories of tau deposition identified in Alzheimer’s disease
2021-04-29
0.02
Single-cell multi-omics analysis of the immune response in COVID-19
2021-04-20
1
Altered perivascular fibroblast activity precedes ALS disease onset
2021-04-15
0.02
Triage-driven diagnosis of Barrett’s esophagus for early detection of esophageal adenocarcinoma using deep learning
2021-04-15
1
Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19
2021-04-09
0.30
Integrative microbiomics in bronchiectasis exacerbations
2021-04-05
0.19
SARS-CoV-2 infection of the oral cavity and saliva
2021-03-25
0.05
Fetal cranial growth trajectories are associated with growth and neurodevelopment at 2 years of age: INTERBIO-21st Fetal Study
2021-03-18
0.48
Plasma metabolites to profile pathways in noncommunicable disease multimorbidity
2021-03-11
0.65
Attributes and predictors of long COVID
2021-03-10
0.70
A Neanderthal OAS1 isoform protects individuals of European ancestry against COVID-19 susceptibility and severity
2021-02-25
0.06
Malaria is a cause of iron deficiency in African children
2021-02-22
0.28
Sixteen novel lineages of SARS-CoV-2 in South Africa
2021-02-02
0.03
Variation in SARS-CoV-2 outbreaks across sub-Saharan Africa
2021-02-02
0.18
Personal neoantigen vaccines induce persistent memory T cell responses and epitope spreading in patients with melanoma
2021-01-21
0.01
The androgen receptor is a tumor suppressor in estrogen receptor–positive breast cancer
2021-01-18
0.17
Microbiome connections with host metabolism and habitual diet from 1,098 deeply phenotyped individuals
2021-01-11
0.46
Pathophysiology-based subphenotyping of individuals at elevated risk for type 2 diabetes
2021-01-04
0.03
Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
2020-12-17
0.97
T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial
2020-12-17
0.98
Characterization of pre-existing and induced SARS-CoV-2-specific CD8+ T cells
2020-11-12
0.06
Rapid pathogen detection by metagenomic next-generation sequencing of infected body fluids
2020-11-09
0.05
Using common genetic variation to examine phenotypic expression and risk prediction in 22q11.2 deletion syndrome
2020-11-09
0.12
Maturation of the gut microbiome during the first year of life contributes to the protective farm effect on childhood asthma
2020-11-02
0.07
Increased circulation time of Plasmodium falciparum underlies persistent asymptomatic infection in the dry season
2020-10-26
0.05
Modeling COVID-19 scenarios for the United States
2020-10-23
0.01
A global survey of potential acceptance of a COVID-19 vaccine
2020-10-20
0.13
Discovery and validation of a personalized risk predictor for incident tuberculosis in low transmission settings
2020-10-19
0.36
Exome sequencing implicates genetic disruption of prenatal neuro-gliogenesis in sporadic congenital hydrocephalus
2020-10-19
0.03
Magnitude, demographics and dynamics of the effect of the first wave of the COVID-19 pandemic on all-cause mortality in 21 industrialized countries
2020-10-14
0.62
Combined PD-1, BRAF and MEK inhibition in advanced BRAF-mutant melanoma: safety run-in and biomarker cohorts of COMBI-i
2020-10-05
0.05
Crowding and the shape of COVID-19 epidemics
2020-10-05
0.28
Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancer
2020-10-05
0.04
Global maps of travel time to healthcare facilities
2020-09-28
0.44
Production, safety and efficacy of iPSC-derived mesenchymal stromal cells in acute steroid-resistant graft versus host disease: a phase I, multicenter, open-label, dose-escalation study
2020-09-14
0.38
Avelumab plus axitinib versus sunitinib in advanced renal cell carcinoma: biomarker analysis of the phase 3 JAVELIN Renal 101 trial
2020-09-07
0.09
Engineering transplantable jejunal mucosal grafts using patient-derived organoids from children with intestinal failure
2020-09-07
1
Genomic copy number predicts esophageal cancer years before transformation
2020-09-07
0.96
Polygenic architecture informs potential vulnerability to drug-induced liver injury
2020-09-07
0.14
17 5.46
20 9.27
16 7.79
32 15.99
60 33.29
87 45.60
379 172.08
170 90.48
104 43.07
144 61.80
47 16.38
51 29.23
39 22.91
13 5.61
341 177.77
Physical Sciences 2357 982.85
Chemistry 1676 926.12
Earth & Environmental Sciences 1260 515.28

1 September 2020 - 31 August 2021

View the connected world of international research collaboration. Visualize collaborations by subject or region.

Collaborations between countries

Percentage of collaboration by Share

Hover over the graph to view the percentage of collaboration.

Top 10 collaborators by Share

  • United Kingdom (UK)
  1. 824.36
    1124.53
  2. Germany (936.39)
    451.32
    485.07
  3. China (767.23)
    289.57
    477.66
  4. France (479.75)
    257.83
    221.93
  5. Italy (361.38)
    191.29
    170.09
  6. Australia (347.53)
    181.29
    166.25
  7. Switzerland (332.21)
    175.12
    157.08
  8. Netherlands (303.81)
    170.31
    133.49
  9. Spain (291.24)
    171.01
    120.23
  10. Canada (243.80)
    132.60
    111.20

Collaboration is determined by the combined fractional count (Share) of United Kingdom (UK) and the collaborating country.

Top 10 institutions from United Kingdom (UK)

Institution Count Share
1. University of Oxford 1406 433.90
2. University of Cambridge 1313 407.80
3. Imperial College London (ICL) 925 241.68
4. UCL 933 214.70
5. The University of Manchester (UoM) 522 139.09
6. The University of Edinburgh 579 136.35
7. University of Bristol (UoB) 452 118.54
8. UK Research and Innovation (UKRI) 693 93.76
9. King's College London (KCL) 432 91.80
10. Durham University 239 78.04

Enhanced profiles

Get your institution here

Return to country/territory outputs